Nov 2022, Express™ Poster

Nov. 11, 2022

“ExPRESS™: An accelerated process for the manufacture of KSQ-001, a CRISPR/Cas9-edited eTIL® product”

© 2024 KSQ Therapeutics, Inc. All rights reserved.